Pharmaceutical Preparations
| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| RTW INVESTMENTS, LP | 13.90M | $434.0M | 8.26% | +600.0K | 2026-06-30 |
| BlackRock, Inc. | 12.44M | $388.0M | 7.39% | +3.69M | 2026-06-30 |
| FMR LLC | 12.33M | $385.0M | 7.32% | +2.43M | 2026-06-30 |
| FARALLON CAPITAL MANAGEMENT, L.L.C. | 12.28M | $383.0M | 7.29% | -- | 2026-06-30 |
| Boxer Capital Management, LLC | 10.88M | $339.0M | 6.46% | -- | 2026-06-30 |
| GOLDMAN SACHS GROUP INC | 9.98M | $311.0M | 5.93% | +4.90M | 2026-06-30 |
| TCG Crossover Management, LLC | 9.08M | $283.0M | 5.39% | -1.45M | 2026-06-30 |
| TRV GP IV, LLC | 6.37M | $120.0M | 3.79% | -- | 2026-06-30 |
| Paradigm Biocapital Advisors LP | 6.36M | $198.0M | 3.78% | +2.35M | 2026-06-30 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 6.35M | $198.0M | 3.77% | +5.46M | 2026-06-30 |
